SEMG1 anticorps (N-Term)
Aperçu rapide pour SEMG1 anticorps (N-Term) (ABIN630160)
Antigène
Voir toutes SEMG1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Semenogelin I antibody was raised against the N terminal of SEMG1
-
Purification
- Purified
-
Immunogène
- Semenogelin I antibody was raised using the N terminal of SEMG1 corresponding to a region with amino acids QKGKQQTESKGSFSIQYTYHVDANDHDQSRKSQQYDLNALHKTTKSQRHL
-
-
-
-
Indications d'application
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
Semenogelin I Blocking Peptide, (ABIN5616040), is also available for use as a blocking control in assays to test for specificity of this Semenogelin I antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SEMG1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- SEMG1 (Semenogelin I (SEMG1))
-
Autre désignation
- Semenogelin I
-
Sujet
- SEMG1 is the predominant protein in semen. The secreted protein is involved in the formation of a gel matrix that encases ejaculated spermatozoa. The prostate-specific antigen (PSA) protease processes this protein into smaller peptides, with each possibly having a separate function. The proteolysis process breaks down the gel matrix and allows the spermatozoa to move more freely.
-
Poids moléculaire
- 51 kDa (MW of target protein)
Antigène
-